Teleflex names former Medtronic executive Sean Salmon to board

• Teleflex named Sean M. Salmon to its board, effective Sept. 8, 2026.
• Salmon spent more than 20 years at Medtronic, most recently as EVP and president of its Cardiovascular Portfolio with fiscal 2025 revenue of about $12.5 billion.
• He also serves as an independent director at Adagio Medical Holdings.
• Salmon will join Teleflex’s Growth and Operating Committee, created earlier this year to support the company’s strategic transformation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teleflex Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260908127211) on September 08, 2026, and is solely responsible for the information contained therein.